Abstract
INTRODUCTION
Ulcerative colitis, a refractory chronic inflammatory bowel disease, has main clinical symptoms of abdominal pain, diarrhea, mucopurulent bloody stool, and tenesmus. Ulcerative colitis is characterized by a slow onset, prolonged course, and recurrence. Decades of research have shown that ulcerative colitis incidence has increased gradually since World War Ⅱ in China. 1 As ulcerative colitis commonly relapses and is intractable, meaning a poor quality of life for patients, it is necessary to find effective treatments. In recent years, special attention has been paid to the content of CD4 +/ CD25 + regulatory T cells (Tregs) and interleukin-10 (IL-10) in the pathogenesis of ulcerative colitis. 2, 3 Wumei pill in Traditional Chinese Medicine (TCM) is prescribed for the treatment of typhoid ascariasis of the biliary tract and dysentery in "Shanghan-Lun", which is a famous clinical tetbook of TCM known in English as the Treatise on Cold Damage Disorders. However, Wumei pill's treatment and immunologic mechanisms on ulcerative colitis are still not clear. This study aimed to investigate the effect of Jiaweiwumei decoction on this disease in terms of regulatory T cells and interleukin-10.
MATERIALS AND METHODS

Materials and reagents
Adult male Sprague Dawley rats with an initial body weight of 225-250 g were purchased from the laboratory animal center, The Fourth Military Medical University (license No. SCXK [Army] 2007-007, Xi'an, China). Rats were maintained in accordance with the guidelines for the care and use of laboratory animals in specific pathogen free conditions. 4 Sulfasalazine suppositories (SASP, 250 mg/tablet) was purchased from Shanghai Sanwei pharmaceutical company (Authorized document number: H31020450, Shanghai, China). Fluorescein isothiocyanate (FITC) labeled CD4 + , CD25 + antibody and IL-10 Enzyme-linked immuno sorbent assay (ELISA) Kit were purchased from Becton, Dickinson, Inc., (San Diego, CA, USA). The traditional Chinese herbal medicine was composed of: Wumei (Fructus Mume) 16 g, Xixin (Herba Asari Mandshurici) 6 g, Ganjiang (Rhizoma Zingiberis) 10 g, Huanglian (Rhizoma Coptidis) 16 g, Danggui (Radix Angelicae Sinensis) 4 g, Fuzi (Radix Aconiti Lateralis Preparata) 6 g, Huajiao (Pericarpium Zanthoxyli Bungeani) 4 g, Guizhi (Ramulus Cinnamomi) 6 g, Renshen (Radix Ginseng) 6 g, Huangbai (Cortex Phellodendri Amurensis) 6 g. Based on the original formula of Wumei pill in TCM, Ruxiang (Olibanum) 6 g and Moyao (Myrrh) 6 g were added to create Jiaweiwumei decoction. All of the herbal drugs were purchased from Beijing Tongrentang pharmacy (Beijing, China). The decoction was prepared as previously described, 5, 6 and concentrated with distilled water before gastric perfusion.
Modeling methods
Rats were fasted for 24 h before the modeling operation, and then anesthetized with 1.5% sodium pentobarbital (2 mL/100 g) via intraperitoneal injection. Rats were fixed in a supine position, and a rubber tube (diameter 2.0 mm, length 12 cm) lubricated with paraffin oil, was inserted through the anus slowly until the splenic flexure. About 8 cm from the anus, a total volume of 0.92 mL of 2,4,6-trinitrobenzene sulfonic acid (TNBS, 100 mg/kg) and absolute ethyl alcohol (1∶1) mixture was slowly injected into the rat. The normal control group was injected with 0.92 mL saline. After keeping the rats in an inverted head-down-hip-high position for about 20 min, rats were allowed to lie and wake. The results of the analysis of pathological changes determined whether modeling was successful.
Grouping and administration
Rats were randomly divided into six groups: normal control group; model group; SASP group; and rats in the high, moderate, and low decoction dose groups, which received 1.428, 0.71, and 0.357 g/mL decoction, respectively, 2 mL orally, once daily. The SASP group received SASP suspension (0.035 g/mL), 2 mL orally, once daily. The normal control group received distilled water 2 mL orally, once daily. All rats were treated for 14 days.
Colon tissue score
After day 14 of treatment, all rats were anesthetized with chloral hydrate. The mesentery was longitudinally opened, and intestinal contents were washed out with cold saline. The colon was flattened. Colon mucosa damage, e.g. congestion, edema, erosion, ulcers, pseudo membrane extent, and area of pathological changes were observed and recorded. The colon tissue morphology score was made according to the reference in Table  1 , and the colon tissue was scored according to the standards of grading. Table 1 Ulcerative colon mucosa injury score criteria ples were then centrifuged at 980 ×g for 5 min. The supernatant was removed, and PBS was used to re-suspend cells. Flow cytometry was used to detect the percentages of CD4+ and CD4+/CD25+ T cells.
IL-10 detection
Serum preparation: Rats were anesthetized with 1.5% sodium pentobarbital (2 mL/100 g) via intraperitoneal injection. Blood was obtained via abdominal aorta. Blood was allowed to clot for 20 min, and then centrifuged 1600 × g for 15 min. Serum was separated and kept at -20 ℃. Tissue homogenate preparation: 6-8 cm of colon from 2 cm upward was cut removed along the longitudinal axis of the mesentery lumen. Lesions (pathological tissues) 0.1 g were obtained and cut into pieces. Then, 500 μL of 0.9% sodium chloride solution was added to prepared 20% homogenate, centrifuged to get the supernatant, and kept at -20 ℃ . IL-10 was detected by double antibody sandwich ELISA (BD Inc., San Diego, CA, USA), in strict accordance with the kit instructions.
Statistical analysis SPSS 13.0 (version 13, Chicago, IL, USA) software was used to process data, which were represented by mean ± standard deviation ( x ± s). One-way analysis of variance was performed and Student-Newman-Keuls test was used to compare differences between two groups. Correlation analysis of regulatory T cell quantity and each index were analyzed using Spearman analysis. P ≤ 0.05 was considered significant.
RESULTS
Comparison of colon injury index
Colon injury index analysis showed statistically significant difference between the model group and normal control group (P < 0.05). There were significant differences between each treatment group and model group (P < 0.05). There was no statistically significant difference between the decoction treatment groups and the SASP treatment group (P > 0.05), as seen in Table 2 . These results suggest that Jiaweiwumei decoction effectively reduced colon injury from ulcerative colitis in rats induced by TNBS, with equivalent efficacy to SASP.
T lymphocyte subset analysis
Peripheral blood T lymphocyte subset analysis showed that there was no significant difference in peripheral blood CD4 + T lymphocyte percentage among the groups (P > 0.05). Compared with that in the control group, the ratio of CD4+/CD25+ to CD4+ T cells was significantly lower in model group rats. Both the SASP and the decoction treatment groups had significantly higher CD4 +/CD25 + to CD4 + T cell ratios (P < 0.05). There were no significant differences between the decoction treatment groups and the SASP group in the T cell ratio (P > 0.05, Table 2 ).
Comparison of IL-10 contents in serum and intestinal mucosa
The IL-10 content in serum and intestinal mucosa of the model group rats was significantly lower than that in the control group (P < 0.05). Meanwhile, the SASP and decoction treatment could effectively improve serum and intestinal mucosal IL-10 content (P < 0.05). There was no significant difference in the content of IL-10 in serum between the decoction groups and SASP group (P > 0.05). Compared with the high dose group, the other treatment groups had a significantly lower IL-10 content in the intestinal mucosa (P < 0.05, Table 2 ).
Correlation analysis between the Treg cell content, colonic damage index, and IL-10 level Correlation analysis indicated that Treg cell content and colon injury index (except the control group) were negatively correlated (r = 0.68, P < 0.05). Treg cell content was positively correlated with that of serum IL-10 (r = 0.87, P < 0.05), and correlated positively with intestinal mucosal IL-10 content (r = 0.79, P < 0.05). Table 2 Colon injury index, peripheral blood CD4+ T lymphocyte subsets (%), and content of IL-10 ( x ± s)
Notes: the normal control group received distilled water 2 mL orally, once daily. High, moderate, and low dose groups received 1.428, 0.71, and 0.357 g/mL decoction, respectively, 2 mL orally, once daily. The SASP group received SASP suspension (0.035 g/mL), 2 mL orally, once daily. All rats were treated for 14 days. CD: cluster of differentiation; IL: interleukin; SASP: sulfasalazine suppositories. Compared with the model group, 
DISCUSSION
The results of this study indicate that the percentage of CD4+/CD25+ T regulatory lymphocytes and the level of IL-10 in the peripheral blood of ulcerative colitis rats was lower than that of the normal rats, which is consistent with previous clinical and animal experimental results. [9] [10] [11] [12] The results of this study also indicate that the TCM Jiaweiwumei decoction at high, middle, and low doses and SASP all decreased the colon index to some extent. This result indicates that the decoction treatment could effectively reduce the colon injury induced by TNBS via increased IL-10 in serum and intestinal mucosa and an increased percentage of CD4+/ CD25+ T regulatory cells in peripheral blood. In addition, correlation analysis of the experimental results shows that the percentage of CD4+/CD25+ T regulatory cells in the peripheral blood was negatively correlated with the scores of colon injury index, and was positively correlated to IL-10. Meanwhile, our results suggest that determination of CD4+/CD25+ T regulatory cells in the peripheral blood could reflect the severity of ulcerative colitis, and could be regarded as an indicator of efficacy evaluation. In TCM, the Wumei pill formula is prescribed for the treatment of typhoid ascariasis of the biliary tract and dysentery in Shang Han Lun. Clinical research has confirmed its curative effect in treatment of chronic ulcerative colitis. [13] [14] [15] [16] Our results indicate that the therapeutic effect of the decoction on experimental ulcerative colitis was significant, and its mechanism was potentially related to a reduction in the intestinal mucosal immune response by up regulating the expression of IL-10 and T regulatory cells, which plays a role in mucosal repair.
